Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Gilead Sciences, Inc. GILD

Healthcare  —  Drug Manufacturers General
150.93 1.24 0.83% as of 25 Sep
Market cap
$183.2B
P/E
0.0×
S&P 500 Member Dividend Champion (10y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Gilead Sciences, Inc. (GILD) Debt to equity

Gilead Sciences, Inc.'s debt to equity at the end of the quarter to 30 June 2026 was 2.2×, up 1.1× from fiscal 2025 (1.1×). Over the past ten years it has ranged from 1.1× (fiscal 2025) to 1.8× (fiscal 2020) — the current reading is the lowest in ten years. That is above the Drug Manufacturers General industry median of 0.6× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Annual

Period Debt to equity Change
FY2025 1.1× (20.56%)
FY2024 1.4× 20.21%
FY2023 1.2× (7.28%)
FY2022 1.2× (5.21%)
FY2021 1.3× (26.61%)
FY2020 1.8× 58.37%
FY2019 1.1× (14.18%)
FY2018 1.3× (20.81%)
FY2017 1.7× 20.88%
FY2016 1.4× 17.14%

Quarterly

Period Debt to equity Change
Jun 2026 2.2× 136.14%
Mar 2026 0.9× (14.16%)
Dec 2025 1.1× (5.15%)
Sep 2025 1.2× (8.72%)
42 more quarters

Against its own ten years

Low 1.1× High 1.8×
Ten-year median 1.3×
Current reading's percentile 9

Debt to equity against peers

Company Debt to equity
SNY Sanofi compare 0.3×
AZN AstraZeneca PLC compare 0.6×
NVO Novo Nordisk A/S compare 0.6×
PFE Pfizer Inc. compare 0.7×
GSK GSK PLC Sponsored ADR compare 1.1×
NVS Novartis AG compare 1.1×
BMY Bristol Myers Squibb Company compare 1.9×
GILD Gilead Sciences, Inc. 2.2×
AMGN Amgen Inc. compare 4.9×
Drug Manufacturers General industry median 0.6×
Healthcare sector median 0.0×
Market median 0.2×

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on GILD